trifluoperazine has been researched along with MS (Multiple Sclerosis) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khaledi, E | 1 |
| Noori, T | 1 |
| Mohammadi-Farani, A | 1 |
| Sureda, A | 1 |
| Dehpour, AR | 1 |
| Yousefi-Manesh, H | 1 |
| Sobarzo-Sanchez, E | 1 |
| Shirooie, S | 1 |
1 other study available for trifluoperazine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice.
Topics: Animals; Cuprizone; Disease Models, Animal; Humans; I-kappa B Proteins; Male; Mice; Multiple Scleros | 2021 |